mortality/aging
N |
• unlike mice homozygous for Nf1tm1Par
and hemizygous for Tg(Fabp7-cre)2Gtm , mice are viable with no reduction in life span
|
nervous system
N |
• unlike mice homozygous for Nf1tm1Par
and hemizygous for Tg(Fabp7-cre)2Gtm no change in pyramidal neuron apical dendrite length or neuritic development are detected
|
• increase in the number of Olig2+ progenitor cells
|
• an increase in proliferating cells is seen in the CA2/3 region
|
• expansion of glial cells similar to that in mice homozygous for Nf1tm1Par
and hemizygous for Tg(Fabp7-cre)2Gtm
|
• increase in the number of GFAP+ astrocytes in the brain
|
growth/size/body
N |
• unlike mice homozygous for Nf1tm1Par
and hemizygous for Tg(Fabp7-cre)2Gtm , no growth retardation is seen
|
endocrine/exocrine glands
N |
• unlike mice homozygous for Nf1tm1Par
and hemizygous for Tg(Fabp7-cre)2Gtm , no impairment in pituitary gland development is detected
|